HomeSMMT • NASDAQ
Summit Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 65.61M | 81.20% |
Net income | -61.20M | -67.37% |
Net profit margin | — | — |
Earnings per share | -0.06 | — |
EBITDA | -65.59M | -81.29% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 412.35M | 121.40% |
Total assets | 435.56M | 114.62% |
Total liabilities | 46.81M | -62.63% |
Total equity | 388.75M | — |
Shares outstanding | 737.68M | — |
Price to book | 37.57 | — |
Return on assets | -34.96% | — |
Return on capital | -37.87% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -61.20M | -67.37% |
Cash from operations | -48.67M | -150.13% |
Cash from investing | 83.48M | 37.83% |
Cash from financing | -23.61M | -477.67% |
Net change in cash | 11.09M | -76.72% |
Free cash flow | -30.75M | -373.78% |
Previous close
$19.91
Day range
$19.59 - $20.59
Year range
$2.10 - $33.89
Market cap
14.90B USD
Avg Volume
2.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2003
Website
Employees
159
